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Tutkimuksen toimeksiantaja oli DelSiTech Oy, jonka patentoitu silika-silika komposiitti 
soveltuu erilaisten lääkeaineiden, viruksien ja pienmolekyylien parenteraaliseen annos-
teluun. Työn tavoite oli tutkia eri komposiittiformulaatioita alhaisella mikropartikkelien 
massakonsentraatiolla (Cmp < 0.5 g/ml), joilla voitaisiin annostella tarvittaessa pienem-
piä lääkeannoksia. Tutkituissa komposiiteissa alennettiin silikahydrogeelin R-arvoa 
(veden suhde silikaattiin) hydrogeelimatriisin mekaanisten ominaisuuksien paranta-
miseksi. Onnistuneelle formulaatiolle määritettiin kolme kriteeriä: komposiitti on ho-
mogeeninen ilman selkeää faasierkautumista, injektoitavissa 27 G-neulan läpi ja lisäksi 
sen viskoelastiset ominaisuudet säilyvät ainakin kolme kuukautta. Ominaisuuksien arvi-
oiminen ajan funktiona oli tärkeää, sillä alennetuilla R-arvoilla kondensaatioreaktion 
jatkuminen geeliytymisen jälkeen on mahdollista useiden kuukausien ajan, muuttaen 
komposiitin rakennetta ja injektoituutta. 
 
Tutkimukseen kuului hydrogeelien valmistus alhaisilla R-arvoilla sekä komposiittien 
valmistus eri formulaatioilla ja kahdella eri menetelmällä. Komposiittien ominaisuuksia 
arvioitiin visuaalisesti ja lisäksi viskoelastisten ominaisuuksien säilymistä 14 päivän 
säilytyskokeella. Lisäksi kahden formulaation injektoitavuutta ja viskoelastisten omi-
naisuuksien kehitystä tutkittiin säilytyskokeissa injektiovoimakokeilla ja oskillaatiomit-
tauksilla kolmen kuukauden ajan +37 celsiusasteessa. 
 
Tutkimuksessa havaittiin alennetun R-arvon altistavan rakenteellisille muutoksille sekä 
hydrogeeleissä että komposiiteissa. Alennetulla R-arvolla ei saatu kompensoitua vähäis-
tä mikropartikkelikonsetraatiota homogeenisen formulaation saavuttamiseksi: useim-
missa formulaatioissa mikropartikkelit sedimentoituivat. Yksi homogeeninen formulaa-
tio, R150 Cmp=0.3 g/ml onnistuttiin valmistamaan, mutta oskillaatiomittaukset ja visu-
aalinen tarkastelu osoittivat näytteiden muuttuvan geelimäisestä kiinteämmäksi ajan 
myötä. Lisäksi näytteiden injektoitavuus oli huono, kertoen faasiseparoitumisesta ja 
näytteiden heterogeenisyydestä. Tutkimuksessa ei onnistuttu valmistamaan homogee-
nista formulaatiota. Tulevaisuudessa voisi tutkia mikropartikkelien lisäämistä jo geeliy-
tyneeseen hydrogeelimatriisiin tai hydrogeelin vahvistamista lisäaineilla matalien mik-
ropartikkelikonsentraatioiden saavuttamiseksi.  
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The mandator of this study was DelSiTech Ltd, whose silica-silica composite is suitable 
for parenteral delivery of pharmaceuticals and viral vectors. The goal of this study was 
to examine low microparticle mass concentrations in the silica-silica composite (Cmp < 
0.5 g/ml), for delivering small doses. As the microparticle concentration was reduced, 
also the R-value of the hydrogel (water to silica alkoxide ratio) was lowered in order to 
improve the mechanical properties of the hydrogel matrix. A successful formulation 
was defined with three criteria: 1) the composite is homogeneous with no visible phase 
separation of hydrogel and microparticles occurring, 2) injectable through 27-G-needle 
and 3) it should maintain its viscoelastic properties for at least three months. Evaluation 
as a function of time was of great importance since continuous condensation reaction 
may go on in the composite for several months and thus alter the composite structure 
and injectability. 
 
The study consisted of preparation of hydrogels with low R-values and preparation of 
composites with several formulations and two alternative preparation methods. Proper-
ties of the composites were evaluated visually and with 14 days storage test. Shelf-life 
studies included evaluation of viscoelastic properties with oscillatory measurements and 
injectability with injection force studies as a function of time for three months at +37°C. 
 
Low R-value was observed to increase structural changes in the composite and hydrogel 
within time. Low R-value did not compensate the lack of microparticles to obtain a ho-
mogeneous formulation. Most of the studied formulations were heterogeneous and sed-
imentation of microparticles often occurred. One homogeneous formulation, R150 
Cmp=0.3 g/ml could be prepared. However, oscillatory measurements and visual obser-
vation showed structural changes within time.  In addition, injectability was poor which 
indicated phase separation and heterogeneity of the samples. Thus, a homogeneous for-
mulation could not be prepared. Suggested methods to obtain low microparticle concen-
trations are addition of the microparticles to a gel or additives to the hydrogels matrix.  
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ABBREVIATIONS AND NOTATION 
23 G  Needle gauge (0.6 x 25 mm) 
26 G  Needle gauge (0.45 x 25 mm) 
27 G Needle gauge (0.4 x 20 mm) 
30 G Needle gauge (0.3 x 13 mm) 
Cmp Microparticle mass concentration in silica-silica composite 
G’ Shear storage modulus 
G’’ Shear loss modulus 
tan(δ) Ratio of shear loss modulus to shear storage modulus 
In situ In the original, or appropriate position 
In vitro Experiments conducted outside living organism 
In vivo Experiments conducted inside living organism 
HAMC Hydroxyapatite–methylcellulose 
HCl     Hydrochloric acid  
Hydrogel    Hydrophilic polymer containing dispersed water in solid network 
structure  
LVE Linear viscoelastic region 
NaOH     Sodium hydroxide 
PAA Poly(acrylic acid) 
PDLLA Poly(D,L-lactide) 
PLGA Poly(lactic-co-glycolic acid  
PEG Polyethylene glycol 
PEO Poly(ethylene oxide)  
PO407 Poloxamer 407 
PVA Poly(vinyl alcohol) 
R-value Molar ratio of water to silica alkoxide  
Silica     Silicon dioxide (SiO2) 
Sol    Colloidal suspension (solid particles in liquid) 
TEOS  Tetraethoxysilane (Si(OC2H5)4) 
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1. INTRODUCTION 
Controlled release systems have gained attention in recent decades due to their signifi-
cant advantages compared to conventional drug delivery systems. In controlled release 
systems, drugs may be delivered to specific target site and with adjustable release pro-
file. In addition, they may take effect for specific duration with reduced frequency of 
administration. [1][2] Drug bursts, which in here refer to rapid increase in concentration 
in bloodstream followed by quick reduction, are a great concern with conventional drug 
delivery systems, possibly resulting in systemic toxicity. A controlled release system 
aims to avoid bursts and moreover, a zero-order release profile with drug release in even 
doses can be achieved. [2] 
A controlled release system consists of a protective cover that controls drug release and 
protects the drug from premature elimination [1]. Microparticles are a popular option in 
encapsulation and localized targeting of drugs [3, p.118–119]. However, combining 
microparticles in a protective matrix may provide more efficient and controlled drug 
release. Hydrogels possess excellent biomimetic properties and they have been exten-
sively studied for drug delivery applications, also combined with microparticles. [4][5] 
The shear-thinning characteristics allows them to deform and flow under external load 
and retain their original shape upon relaxation [6][7]. 
A silica-silica composite represents a unique microparticle/hydrogel composite intended 
for controlled drug delivery. The silica-silica composite has been developed by the 
mandator of this study, DelSiTech Ltd., which is a Finnish company specialized in bio-
degradable silica-based controlled release systems. Both components of the composite, 
microparticles and hydrogel, consists of biodegradable amorphous silica. The main 
components of the hydrogel matrix are silica nanoparticles which are formed and aggre-
gated in sol-gel process, constructing a typical three-dimensional gel network. Particles 
are formed in condensation of silica molecules which is highly dependent on pH [8, p. 
103–105]. As nanoparticles form and aggregate, viscosity of the nanoparticle suspen-
sion (sol) increases. Mixing of microparticles and sol also drives the gelling process as 
the microparticles act as nucleating agents [9, p. 479]. As a conclusion, as gelation oc-
curs, viscosity of the sol rises quickly enough to adequate level to prevent microparticle 
motion and sedimentation in the matrix.   
Drug dosing is dependent on many factors including the size of a patient [10][11]. The 
ease of adjusting dosing is a great advantage of microparticles in controlled drug deliv-
ery systems: simply by reducing the amount of microparticles, a lower drug dose can be 
achieved. However, as they are embedded in a hydrogel matrix, reduction of micropar-
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ticles will evidently alter the mechanical properties of the composite as well as the gela-
tion time. Reduction of nucleation points increases gelation time, exposing microparti-
cles for sedimentation. To prevent microparticle sedimentation, modification of the sili-
ca hydrogel matrix may provide a solution. Silica hydrogel R-value describes the molar 
ratio of water to silica alkoxide. By decreasing the ratio, the amount of water is reduced 
in the hydrogel structure, resulting in better mechanical properties and decreased gelling 
time. [8, p. 126][12] Reduction of microparticle mass concentration (Cmp) and hydrogel 
R-value at the same time may allow even distribution of microparticles in the matrix.  
The goal of this study was to examine if a homogeneous formulation could be manufac-
tured with R-value < 300 and Cmp < 0.5 g/ml, preferably < 0.3 g/ml. Homogeneous 
composite refers to a composite with no visibly distinct phase separation occurring. The 
goal was to use fresh, unaged sols in silica-silica composite preparation, indicating that 
microparticles and sol are mixed immediately after sol is prepared and pH is set to 6.2. 
The main objectives for a successful formulation were that they are homogenous, in-
jectable through 27 G hypodermic needle and maintaining their viscoelastic properties 
for at least three months. The studied parameters included influence of low R-value on 
hydrogel structure and determination of lowest possible R-value still applicable in com-
posite preparation, manufacturing composites with several formulations and conducting 
shelf-life studies on suitable formulations. Shelf-life studies evaluated viscoelastic 
properties and injectability of the composite as a function of time. Time is an important 
constraint since condensation may occur for months after gelation and result in structur-
al changes [8, p. 358‒362]. Viscoelastic properties and gel structure of the composites 
were evaluated by oscillatory measurements with small angle oscillatory shear. Injecta-
bility of the composites were studied with injection force studies. The injections were 
performed through 27 G needle. 
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2. THEORETICAL SECTION 
2.1 Biomaterials in drug delivery 
The concept of biomaterial is often used to describe materials that are in contact with 
biological systems. Even though biomaterials are used in many other applications than 
only medical ones, the focus usually lies on medicinal products that ones are also rele-
vant in this study [13, p. 4][14][15, p. 1]. However, the definition of biomaterial and 
related concepts are somewhat miscellaneous. In 1987, the first consistent definition 
was established, defining biomaterials as “nonviable materials that are used in medical 
devices and are intended to interact with biological systems.” [16] The definition is al-
tering in different sources, and by removing the word medical from the definition, the 
definition of biomaterial is more diverse [15, p.1–2][16]. However, the main idea of 
biomedical biomaterials by 1999 definition is that the “material is intended to interface 
with biological systems to evaluate, treat, augment or replace any tissue, organ or func-
tion in the body.”[16] 
There are many ways to categorize biomaterials. They can be classified into four differ-
ent groups based on their interaction in the human body: toxic materials which cause a 
harmful response and lead to tissue death, biologically inactive materials that are encap-
sulated by fibrous capsule in the body and are thus nearly inert, bioresorbable or biode-
gradable materials that dissolve while in contact with tissue and body fluids and bioac-
tive materials that elicit a specific biological response that leads to the formation of a 
bond between tissue and the material. [17, p. 252][18]  
Biocompatibility is an additional concept that needs to be defined. Unfortunately, there 
is no exact definition for biocompatibility other than in medical context, where it usual-
ly refers to materials having successful performance in their intended task. Biocompati-
bility is most often used to refer to tissue reaction to an implant or foreign material in 
which no great inflammation occurs. The concept of successful should be defined sepa-
rately for each application. [15, p. 2] 
The eventual disappearance of a material or device after being introduced into a biolog-
ical system can be described as bioerosion, bioabsorption, biodegradation or bioresorp-
tion [19, p. 116]. Degradation refers to molecular breakdown or clearance of covalent 
bonds of a polymeric material and with addition of prefix “bio”, it refers to degradation 
by at least partly biological activities [19, p. 116][20, p. 177][21]. Bioabsorption and 
bioresorption refer to total removal of polymer and degradation products by cellular 
activity, being also somewhat superfluous terms [19, p. 116]. Erosion refers to loss of 
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the material, monomers and oligomers leaving the polymer by complicated processes. 
However, polymer degradation is a key process of erosion. Thus, erosion can be under-
stood as a process mediated by some other processes, for example degradation [21]. 
Erosion processes can be divided into two main categories which are surface and bulk 
erosion. Surface eroding materials lose material only from surface and keep their origi-
nal shape. For bulk eroding materials, erosion and degradation are not restricted to sur-
face [22]. 
Hydrogels represent a biomaterial group that have attracted attention in biomedical and 
pharmaceutical research. Especially, hydrogel-based drug delivery is attractive due to 
versatility of hydrogels and possibility of network tailoring [4]. In addition, a system 
with microparticles embedded in a hydrogel matrix offers a unique alternative for drug 
delivery [5]. 
 Hydrogels 
Hydrogels are hydrophilic polymers that have three-dimensional configuration and are 
capable of absorbing significant amounts of water or other biological fluids. They can 
swell in aqueous media [13, p. 19][23, p. 75][24][25]. The capability of absorbing water 
is attributed by the presence of hydrophilic groups, such as -OH, -CONH or -SO3H in 
polymer structures [25]. Water content in hydrogels is over 50 wt-% and can be even > 
95 wt-% [26]. Degradation of hydrogels occurs by enzymatic activity, hydrolysis and/or 
dissolution [27]. 
The basic hydrogel microstructure can be described as a continuous polymer network. 
The continuous network is provided by interactions between the species [25]. Porosity 
and mesh size are important features of hydrogels which on the other side often play an 
important role in controlled release systems. Typically, the mesh size of biomedical 
hydrogels is around 5 to 100 nm at swollen state [13, p. 22][25][28, p. 230]. 
Hydrogels can be either physical or chemical hydrogels, based on how the crosslinks 
are formed [25]. Physical hydrogels form by aggregation, association, crystallization, 
complexation or hydrogen bonding or in other words by physical interactions. Physical 
gels are often reversible: they may dissolve by changing environmental conditions, such 
as pH, temperature or the ionic strength of solution [29]. Chemical hydrogels are con-
structed from chemical covalent crosslinked network in which covalent bonds join dif-
ferent macromolecular chains [23, p. 76][29]. 
In addition, hydrogels can be categorized based on their origin. They may be construct-
ed of natural or synthetic polymers. Natural hydrogels may constitute from for example 
proteins, natural gums, cellulosic materials, hyaluronic acid, collagen and polysaccha-
rides [30]. Synthetic hydrogels include for example poly(ethylene oxide) (PEO) and its 
copolymers, poly(acrylic acid) (PAA) and its derivates, poly(vinyl alcohol) (PVA) and 
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polypeptides [27]. Hydrogels made from natural polymers possess high biocompatibil-
ity but lack mechanical properties. On the other hand, synthetic polymers have usually 
more defined structures and their properties can be tailored [4]. 
To achieve customized functionality of hydrogels, several types of hydrogel composite 
materials have been developed. Nanocomposites or hybrid hydrogels are formed either 
from chemically or physically linked polymer network with nanoparticles or nanostruc-
tures. Nanocomposite hydrogels can be made from various particles, such as from pol-
ymeric nanoparticles, inorganic nanoparticles or carbon-based nanomaterials. As an 
advantage, they offer excellent formability of their properties and especially improved 
mechanical properties. [30][31] For example, the addition of silica nanoparticles to 
poly(ethlylene glycolide) (PEG) hydrogels was studied to enhanced mechanical proper-
ties and cell adhesion characteristics [31]. 
The use of hydrogels in drug delivery and tissue engineering is attractive since they 
possess some excellent biomimetic properties, including the ability to resemble physical 
properties of living tissues, low interfacial tension with water or biological fluids and 
excellent biocompatibility [4][24][25]. In addition, hydrogels have been proven to be 
suitable carriers for fragile biomolecules, such as proteins due to the lack of hydropho-
bic interactions which could possibly denature the proteins. Hydrogels can be also tai-
lored at manufacturing state to response to external stimuli, for example to pH. It must 
also be noted that there are many design variables that affect to the drug release such as 
hydrogel composition, temperature, pH and ionic strength. [4] Some limitations exist in 
hydrogel drug delivery: homogeneity of drug loading may be difficult to obtain, espe-
cially with hydrophobic drugs. In addition, a high water content and large pore sizes 
may result in rapid drug release, even in some hours [5]. The diversity of applications 
may be simplified by using following categories: oral hydrogel systems, topical hydro-
gel systems, transdermal hydrogel systems, gastro-intestinal hydrogel delivery systems 
and ocular hydrogel delivery systems. In addition, there are other experimental routes 
for hydrogel-based drug delivery, such as vaginal and nasal delivery. [25] 
 Microparticles in hydrogel matrix 
Microparticles can be efficiently used for localized targeting of drugs, referred to as 
particulate systems. Types of particles can be for example microspheres, nanoparticles 
or micelles. The microsphere size is from 1-1000 µm. For injectability, particle size 
under 100 µm is typically preferred. [3, p.118–119] Nanoparticles, on the other hand, 
are typically under 0,01 μm [32, p. 1]. Microparticles have generally large ratio of sur-
face area and volume [20, p. 189]. It is possible to produce micro- and nanoparticles in 
different shapes and sizes by controlling the particle synthesis which increases their 
versatility [32, p. 16]. 
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In drug delivery, microparticles are attractive for several reasons. For example, doses 
can be easily adjusted. In addition, administration is simple since the microparticles can 
be injected through fine needles which in turn increases the acceptance from the pa-
tients. Some challenges in use of microparticles include impossibility of removal after 
entering the body, large surface area that may promote aggregation and limited drug 
load level. There are multiple methods to encapsulate drugs into microparticles. For 
example, emulsion methods and spray-drying are typical for encapsulation. [8, p. 187, 
192] Spray-drying will be the only one discussed here. It is a useful method for micro-
encapsulation, since it offers the possibility to predetermine properties such as particle 
size and porosity, flowability and preservation of activity of heat sensitive pharmaceuti-
cals [33]. 
Microparticles may be combined with physical hydrogels. The embedded substances do 
not only restrict to microparticles: liposomes, microgels, microemulsions, surfactant 
micelles and polymeric micelles can be entrapped in a hydrogel matrix [5]. Microparti-
cle hydrogel composite can be considered as a multiphase system. Interfaces in multi-
phase systems can be described with structural, mobility and interaction characteristics. 
Structural characteristics include morphological and charge arrangements in material 
units that are taking part as micro- and nanoscale interlayers are formed. In principle, 
material morphological features in the interfacial region are affected by local shear forc-
es, mobility of adjacent segments and interaction between involved groups of the phas-
es. Molecular or segmental mobility can be restricted by a strong interaction. This in 
turn leads to a stable, amorphous structure at the interface. Local shear forces may also 
initiate orientation of the interface structure. Mobility is a second characteristic which is 
greatly affected by the interfacial structure and describes adhesion and molecular 
transport in the material. For example, adsorption is driven by amount of free energy. 
Materials with high surface energy, adsorption of water molecules is often occurring in 
normal conditions. Adsorbed layer may cause difficulties in processing, such as water 
release, decreased adhesion and aggregation. As a third category, interactions refer to 
physical or chemical bonds between phases and also activation and inhibition of chain 
growth or degradation reactions. [34] 
The combination of hydrogel and microparticles has several advantages in pharmaceuti-
cal applications. Firstly, the degradable hydrogel controls the release of the drug. The 
hydrogels matrix acts also as an additional diffusion barrier and thus controls the drug 
release [5]. A drug may first diffuse to the hydrogel matrix and after that be released to 
its target site [26]. However, with small drug molecules, the hydrogel matrix may not 
affect to the release rate of the drug [36]. Additionally, high water content in the hydro-
gel may promote dissolution of certain particles [37]. By only using microparticles, 
there is a greater risk for burst release [20, p. 189]. Bursts and drug release will be dis-
cussed in chapter 2.4.2 Secondly, microparticles may be used to stabilize the composite 
[38, p. 283]. 
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Microparticle composites have been utilized in pharmaceutical applications, constructed 
from different polymer combinations. Poly(lactic-co-glycolic acid) (PLGA) microparti-
cles have been used in several studies, combined with collagen scaffold for parenteral 
administration, poloxamer 407 (PO407) gel, PVA hydrogel, chitosan-graft-poly(N-
isopropylacrylamide (PNIPAM-g-chitosan) matrix and hyaluronic acid/methylcellulose 
(HAMC) hydrogel. [36][39][40][41] In addition, studies have been conducted with 
poly(D, L-lactide) (PDDLA) microparticles and PEG based copolymers [42]. The tech-
niques of embedding microparticles in the matrix include lyophilization and casting, 
mixing in +4°C before matrix forms a gel and by adding microparticles to a solution 
with vigorous stirring (5000 rpm) [35][36][39][40]. In conclusion, microparticles are 
usually embedded in a solution that forms a gel.  
2.2 Rheology and injectability  
In principle, rheology studies the material properties and structure that cause the typical 
behavior of a material, for example its flow and deformation. More specifically, the 
effects on applied forces to the rate of deformation and flow are of great interest and the 
goals are to establish a relationship between applied forces and deformation and be-
tween rheological properties and material structure. One goal is also to establish models 
that help in qualitative or quantitative analysis of experimental results. [43, p. 2‒4] 
However, rheological properties are not simple to predict since they are dependent both 
on time and measuring conditions [44, p. 18].  
Rheology is an efficient method to characterize hydrogel degree of crosslinking, struc-
tural homogeneity or heterogenicity and molecular weight and it requires only small 
sample volume and good sensitivity. With hydrogels, rheological studies are usually 
conducted with small-amplitude oscillatory shear (SAOS). [45]  
 Shear stress and shear rate  
To understand fundamentals of rheology and especially flow behavior, some parameters 
that affect the deformation and flow must be determined. The two-plates model is con-
venient in here since it is applicable in the studies (figure 1).  
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Figure 1. Two-plate model. F presents the shear force, A the plate area, h the distance 
between plates and v the velocity. Modified from source [44, p. 19] 
The two-plates model consists of a moving upper-plate with a shear area A and the 
movement is caused by shear force F. The force moves the upper plate at velocity v, the 
lower plate is stationary.  Distance between plates is h and the sample (liquid) is placed 
in the gap. [44, p. 19] 
Shear stress (τ) can be defined as the ratio of shear force to shear area [44, p. 19]. The 
force is tangentially applied to the area. Shear stress causes the liquid to flow in a cer-
tain pattern, having the highest velocity near the upper plate and the lowest velocity 
near the lower plate. The velocity of the flow that can be maintained for a given force is 
controlled by the viscosity or internal resistance of the fluid. [46, p. 15, 21] 
The model assumes that no slip occurs between the plates and the sample adheres to 
both plates. In addition, the flow between the plates is laminar, in the form of layer [44, 
p. 19]. Hence, the flow consists of thin liquid layers sliding on top of each other. A 
speed drop that occurs between the plates, by displacements of laminar layers is referred 
as shear rate (γ´) and it describes the ratio between the velocity and distance between 
the plates. [46, p. 16]  
Thus, shear stress and shear rate describe the force to accelerate flow in a liquid and the 
velocity profile between two plates. Their ratio can also be abbreviated as shear viscosi-
ty.  [44, p. 24] The connection between shear stress and shear strain and for viscosity 
and shear rate for different materials can be observed in figure 2. [46, p. 21] 
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Figure 2. Flow curve and viscosity curves. Curve number one represents a Newtonian 
liquid; the rest are non-Newtonian. Curve number two shows the behavior of a shear-
thinning material. [46, p. 21] 
There are several models to describe liquid flow behavior. Generally, they are divided 
to Newtonian liquids that follow ideal flow behavior and Non-Newtonian liquids which 
do not. In general, for Newtonian fluids shear rate is linearly dependent on shear stress 
and viscosity is not dependent on shear rate, which is not the case for non-Newtonian 
fluids. [46, p. 21‒22] 
 Viscoelastic and mechanical behavior of hydrogels 
Elastic behavior of materials can be characterized as the capacity to store mechanical 
energy without any dissipation of energy. Another characteristic of elastic response is 
that materials exposed to a suddenly applied loading respond instantly and deformation 
remains constant. A viscous fluid in a non-hydrostatic stress-state has the ability of dis-
sipating energy and not storing it. In addition, a viscous fluid flows steadily as uniform 
shear stress is applied. [47, p. 1] However, the behavior of a material can be a combina-
tion of the two models, simultaneously exhibiting viscous and elastic behavior and thus 
displaying a delayed response to applied load [44, p. 80][48, p. 300]. Viscoelastic be-
havior is especially prominent in polymers. An important aspect of viscoelasticity is that 
the mechanical behavior of a viscoelastic material is both time and temperature depend-
ent  [48, p. 300].  
The ability to store and dissipate energy during deformation are described with Young’s 
store modulus (E’) and loss modulus (E’’). Equivalently, the same characteristics in 
shear may be named as shear storage modulus (G’) and shear loss modulus (G’’) [48, p. 
300, 306]. G’ describes the elastic portion and G’’ the viscous portion and in a gel, G’ is 
dominating since the continuous phase is the solid phase [24]. Their ratio, G’’/G’, can 
be expressed as tan(δ) [43, p. 336] which in case of gel is <1 [26]. 
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Mechanical properties of hydrogels are highly dependent on the network structure, es-
pecially on cross-linking density, degree of swelling and on environmental conditions 
[12][41]. Degree of swelling or extent of hydration is again, governed by the chemical 
structure of the polymer and degree of crosslinking [13, p. 20]. The mechanical behav-
ior of hydrogels is commonly explained with theories of rubber elasticity and viscoelas-
ticity. The response of hydrogels under mechanical stress vary significantly: response 
may be rapid, elastic recovery or a time-dependent recovery, indicating viscous behav-
ior [49]. At swollen state, most hydrogels possess rubber-like behavior and may under-
go fully reversible deformation under external load [12]. 
Mechanical strength can be altered by for example increasing crosslinking density by 
crosslinking agents or by changing the reaction conditions. Most of them aim to reduce 
the degree of swelling or the water content in the hydrogel. Thus, water content has a 
significant effect on the mechanical properties of the hydrogel. For example, if hydro-
gels are subject to water loss during testing, it can significantly influence the mechanical 
behavior. As temperature increases, water loss also increases which leads to subsequent 
changes in the hydrogel structure. This in turn leads to rising moduli values with tem-
perature. [12] 
However, hydrogel/ microparticle composites possess more complex behavior since 
they consist of several components [51, p. 587]. Viscoelastic properties of hydro-
gel/microparticle composite are mainly dependent on the rigidity of the matrix, the ri-
gidity and volume fraction of the filler which are here the microparticles, and interaction 
between microparticles and matrix. [50][51, p. 585]. In case the rigidity of the particles 
is higher than the rigidity of hydrogel matrix, the particles have reinforcing effect on the 
composite. The stiffening effect of microparticles can be expressed as the ratio of G’-
value of the composite to G’-value of the matrix.  However, accurate modelling consid-
ers an idealized composite material: microparticles should be of approximately the same 
size and uniformly distributed.  This means that the composite material is macroscopi-
cally homogeneous. [50]  
Viscoelastic behavior can be explained for many materials by generalized models, for 
example Maxwell model for viscoelastic fluids and Kelvin model for solids [47, p. 19]. 
In addition, the complex behavior of composite gels can be modelled with several mod-
els, including Van der Poel-Smith’s model and Kerner-Lewis model [42]. Flow behav-
ior can be simplified for interpretation with mathematical models for curve fitting, such 
as the Power-Law for shear-thinning fluid. [44, p. 53].  
 Shear-thinning hydrogels and their injectability 
As a subcategory of non-Newtonian fluids, some fluids are pseudoplastic (shear-
thinning) and their viscosity drops at higher shear rates which for example allows in-
jectability of a material [46, p. 21]. The shear-thinning flow behavior is not uniform at 
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very low to very high shear rates. At low shear rates, the Brownian motion of molecules 
causes the particles to be in random positions regardless of shear orientation. Thus, at 
very low shear rates, shear-thinning liquids behave similarly to Newtonian liquids and 
have a zero shear viscosity (η0) which is independent of shear rate. When the shear rate 
increases, at some point the shear induced molecular or particle orientation begins to 
dominate the Brownian motion which causes the viscosity to drop significantly. At ex-
tremely high shear rates, the viscosity will begin to approach a constant level. At that 
point, a perfect orientation is reached and the behavior is no longer shear-thinning. [46, 
p. 23]  
Injectability may be defined as the ratio of mass of injectable material able to be extrud-
ed from a syringe until a maximum force is reached to the initial mass of the material in 
the syringe [52]. Shear-thinning hydrogels can be injected directly through a syringe 
and then undergo a rapid sol-gel transition at their target site. Shear-thinning hydrogels 
in biomedical applications may constitute from peptides, proteins, hydrogel blend or 
colloidal systems, consisting on colloidal particles [6][7]. Hydrogels may form cross-
links in-situ which refers to gelation at their target site. Thus, the injectable product is a 
solution, not a gel. Formation of crosslinks may be induced by temperature, pH, ion-
concentration or hydrophobic interactions. In addition, hydrogels that gel in vitro may 
be used as injectable material. Some physical hydrogels may exhibit viscous flow under 
shear stress and then time-dependent recovery once shear stress is removed. [6] Shear 
thinning hydrogels may orientate during injection in a way that they possess shear-
thinning behavior as external force is applied to the plunger of the syringe and flow 
more easily [53]. Shear-thinning behavior arises from the microstructure of the material 
and the effect of shear in different materials is shown in figure 3 [54]. 
 
Figure 3. Microstructures at rest shown above and under shear shown below. From 
left: polymer chains disentangling, emulsion droplets reorganizing and deforming, 
elongated particles aligning with the flow and aggregated structures breaking down to 
primary particles. [54] 
The case on far right in figure 3 presents the situation in physical hydrogels. The 
nanoaggregates go through reorientation and break down to primary particles in injec-
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tion [7][54]. Viscosity drops significantly since particle interaction decreases and free 
space between dispersed components increase because of reorientation [55]. Once such 
materials are introduced to physiological conditions, they reorganize and retain their 
hydrogel structure [53]. Viscosity is quickly retained to the original level as shearing is 
slowed down or terminated [46, p. 23]. Recovery time is important in drug delivery ap-
plications. If the recovery time is too long, sedimentation or leakage of the encapsulated 
substances may occur [6]. 
In successful injection, three requirements must be fulfilled: no blocking of the needle, 
even flow of the injected product and suitable force. Needle gauge has a significant ef-
fect on injectability since the shape, inner diameter, surface finish, length and shape of 
the opening are all influential to the flow of the product. In addition, variables such as 
viscosity affects to injectability. [55] The applied force in injections dissipates in three 
ways including overcoming the resistance force of the syringe plunger, imparting kinet-
ic energy to the material and forcing the material through the needle. Additionally, force 
is also required for administration to any medium, in here to the subcutaneous tissue. 
[56] Force is an important variable in injections. Generally, 80 to 100 N can be consid-
ered as a maximum finger pressing force of an adult, depending also on gender and age 
[57]. Viscosity of the material is significantly affecting to the injection force. In protein 
solutions, high concentrations have been studied to increase the injection force [56][58]. 
As mentioned, some composites exhibit complex mechanical but also rheological be-
havior. A two-phase system is especially fragile to phase separation during injection. In 
pharmaceutical applications, phase separation is a common phenomenon in extrusion of 
biphasic pastes. Some mechanisms of phase separation have been recognized during 
injections in which the pressure is the driving factor. The two main categories are filtra-
tion in the needle and filtration in the barrel. Phase separation may be induced by filtra-
tion in the needle, where the pressure causes the liquid to flow along the needle more 
rapidly than the solid phase. This causes regions of high solid volume fraction. Filtra-
tion may also occur in the barrel:  the pressure exerted by the plunger on the material 
causes the liquid phase to quickly flow and redistribute. In contrast, the solid phase in-
tegrates and may be present as static regions, especially on both sides of the barrel exit. 
[52] In microparticle composites, as microparticle concentration is lowered, the me-
chanical properties of the composite weaken which decreased ability to withstand ap-
plied stresses also in injection [50].  
 Oscillatory measurements 
Oscillatory measurements allow to determine elastic and viscous material properties 
with non-destructive methods. The principle is to induce forced oscillating stress by 
rotation with a small angle to the left and to the right and to study the influence of the 
frequency on storage and loss modules [44, p. 114][59, p. 122]. A viscoelastic material 
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responses to oscillating strain with stress that lags by phase angle (δ). This is presented 
is figure 4.  
 
Figure 4. Viscoelastic material response to oscillating strain. The stress is out of phase 
with the strain by phase angle (δ). [60, p. 100] 
The stress is out of phase with the strain. Hence, a portion of the energy is saved and in 
phase and dissipated energy will be out of phase with the applied strain. A viscoelastic 
material elicits a phase shift between 0-90°, from 90° at low frequencies to 0° at highest 
frequencies. Storage modulus and elastic modulus can be applied to describe the oscilla-
tion system with the following equations: 
   𝐺′(𝜔) = 𝐺∗(𝜔)cos⁡(δ)      (4) 
   𝐺′′(𝜔) = 𝐺∗(𝜔)sin⁡(𝛿),      (5) 
where 𝜔 is the radial frequency and G* is the complex modulus or ratio between stress 
and strain. [60, p. 100‒104] The applied stress causes the material to undergo defor-
mation (γ) [59, p. 80]. 
Oscillatory measurements are usually conducted in the linear viscoelastic region (LVE). 
At the LVE the G’ and G’’ are independent of stress or strain values [59, p. 82]. In 
LVE, the sample retains its structure. If the stress is high enough, the sample is de-
formed and the internal temporary bonds of aggregates are destroyed. In addition, shear-
thinning begins and a major part of the energy is irreversibly lost as heat [46, p. 133]. 
The LVE limit can be determined by amplitude sweep (figure 5) [61]. 
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Figure 5. Illustration of the LVE (abbreviated as LVR) region. The LVE region ends 
when the plateau of G’ values end.  [38] 
As seen in figure 5, at the LVE (abbreviated as LVR) G’ values are in a plateau and 
then decrease as stress is increased. The sweep can be done with a controlled defor-
mation (CD) program where the instrument will detect the necessary stress value to ac-
complish the requested deformation and thus plot G’ and G’’ values as a function of 
deformation. [59, p. 80] 
There are several oscillation measurements modes that can be conducted to characterize 
materials [59, p.77‒90]. Rheological properties study of hydrogels can provide infor-
mation on their structure and on the viscoelastic properties as well as the network pa-
rameters within the hydrogels. However, it must be noted that rheological behavior of 
hydrogels is also strongly dependent of environmental conditions [62]. Oscillation fre-
quency sweep is a typical procedure to characterize structural conditions of gels 
[51][59, p. 80]. In frequency sweep, the G’ and G’’ values are plotted as a function of 
frequency at constant temperature [61]. 
In gels, the three-dimensional network forms a continuous structure and in frequency 
sweep and they should be showing G’>G’’ at the whole frequency area. Elastic behav-
ior dominates the viscous one. In addition, the G’ and G’’ curves are often almost paral-
lel curves, showing only a slight slope. [44, p. 141]  
In addition, homogeneity of the samples is an important measuring constraint in rheolo-
gy. Homogeneity of the sample meets the requirements of rheological studies when the 
sample shears uniformly. This can be problematic in case of dispersion or suspensions 
but also for composites [46, p. 31‒32]. Suspensions and filled polymers, for example, 
cannot be considered as homogenous in principle [43, p. 40]. Phase separation might 
occur at high shear rates and cause a liquid layer on top of the sample [44, p. 32]. Inho-
mogeneous material may lead to irregular distribution of stress and strain throughout the 
material [50]. 
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2.3 Silica-silica composite 
Silica-based drug delivery systems have been rapidly developed during the past dec-
ades, including applications such as targeted drug mechanism studies, drug kinetics 
marker in pharmacological research and evaluation of the effectiveness of the drug re-
lease in diagnosis and therapy [63]. In addition, an advance of silica-based controlled 
drug delivery systems is that they can be functionalized to response environmental 
changes such as to changes in temperature, pH, magnetism and luminescence [65]. 
Silica microparticles have also been combined with organic materials for pharmaceuti-
cal applications. However, combining the microparticles with a matrix that is the same 
material but owing a different state is a clear advantage in terms of toxicology, product 
development and function. If the same chemical substances are for preparing the hydro-
gel and the microparticles, the impurities stay low and there is no need to study the 
combination effects of different substances. Biodegradation mechanism is simpler to 
predict than when using a combination of silica and organic polymers. [26] 
 Silica chemistry 
Silicon is the second most ample element on Earth and is mostly found as materials con-
taining silicon, referred to as silicates. The ubiquitous presence of silicon occasionally 
causes confusion in the terminology. Silicon refers to the element and silicone or pol-
ysiloxanes to a family of polymers with silicon-oxygen back-bone. Silicon compounds 
are synthetic polymers where carbon atoms are connected to silicon atoms. Silica refers 
to silicon dioxide (SiO2) and to chemically combined forms. [13, p. 109-110] 
Structurally, silica consists of a three-dimensional network in which every corner oxy-
gen atom in each tetrahedron is shared by an adjacent tetrahedral [66, p. 426]. Silica 
contains Si-O bonds, that are relatively stable compared to other Si-X bonds. Silica may 
be present in both crystalline and amorphous forms, crystalline silica forming regular 
structure from SiO4 units and amorphous silica by random packing of SiO4 units [67, p. 
10]. Hydroxylation of the surface of amorphous silica is an important phenomenon. A 
fully hydroxylated silica particle is presented in figure 6. 
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Figure 6. A model of a fully hydroxylated silica particle. The figure is two-dimensional 
and the fourth oxygen coordinated with the Si-atom is behind the particle or towards 
the reader. [67, p. 17] 
A sufficient amount of OH -groups causes the hydrophilicity of the silica surface. The 
surface OH-groups mainly cause the adsorption of water molecules [67, p. 22]. Moreo-
ver, the R3Si–O bonds are called silanol groups [68]. Silanol groups can be further cate-
gorized but will not be discussed here.  
Polymerization of silica in aqueous systems differs from other organic polymers formed 
by simple condensation. Instead of linear polymer formation, the monomers form parti-
cles which slowly grow and finally aggregate and link into chains [8, p. 99‒100][53]. 
Silica hydrogel belongs to physical hydrogels since silica nanoparticles aggregate and 
crosslinks are provided by van der Waals interactions [53]. Polymerization will be dis-
cussed in chapter 2.3.2. 
Nanoscale particles that form the silica hydrogel network by aggregation are colloidal 
[53]. Colloidal silica refers to dispersed systems in which silica is the disperse phase. 
Colloidal particles are defined as particles with a size sufficiently small (≤1µm) not to 
be affected by gravitational forces but sufficiently large that short-range forces, such as 
van der Waals attraction and surface forces are dominating the interactions. The parti-
cles exhibit Brownian motion which means the random movement of particles, driven 
by the momentum of random collisions with molecules of suspending medium. Hence, 
colloidal dispersion is defined as a system in which particles of colloidal size of any 
phase are dispersed in a continuous phase owning a different composition. [8, p. 2][67, 
p. 1] In case of silica microparticles, the system is not colloidal anymore. The nanoag-
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gregates form a microparticle which is large enough to be affected by gravitational forc-
es [53]. 
 Sol-gel processing  
Sol is defined as the colloidal suspension of solid particles in liquid [8, p. 2]. Colloidal 
suspensions are biphasic systems where the interparticle forces of discrete phase are in 
significant role in governing system properties [50]. Hence, in a silica-silica composite, 
the silica nanoparticles represent the solid particles. In a sol, the liquid phase is the con-
tinuous phase [53]. Gel is defined as a colloidal dispersion in which solid phase is the 
continuous phase and liquid is the dispersed phase [26]. In gelling, the silica nanoparti-
cle aggregates to form a continuous network [53]. 
Sol-gel derived silica is prepared from metal alkoxides which have an organic ligand 
attached to metal atom. Metal alkoxides are often used as precursor since they react 
easily with water. The most common tetraalkoxysilanes that are used as precursor are 
tetraethoxysilane (SiC8H20O4) and tetramethoxysilane (SiC4H12O4), often referred as 
TEOS and TMOS, respectively. [8, p. 2‒3, 112] 
The sol-gel processes of silica can be divided in three phases and two main reactions: 
hydrolysis followed by condensation in two steps. The system can be identified as a 
two-step inorganic polycondensation. Three equations are presented below. [64] 
Hydrolysis: 
Si‒OR + H20 → Si–OH + ROH        (1) 
Condensation: 
–Si–OR + Si–OH → Si–O–Si + ROH       (2) 
–Si–OH + Si–OH → Si–O–Si + H2O       (3) 
At the first step, hydrolysis occurs, performed with a presence of a catalyst to obtain the 
most rapid and complete process. Generally, mineral acid or ammonia are used. The 
alkoxide groups (OR) are replaced with hydroxyl groups (OH). Condensation reactions 
involve silanol groups producing siloxane bonds (O–Si–O) and as a byproduct alcohol 
(ROH) or water. Alcohol is used typically as homogenizing agent since both water and 
alkoxide are immiscible. However, the alcohol byproduct is enough to homogenize the 
two-phase system. Condensation aims to maximize the amount of Si–O–Si bonds and 
thus to minimize the number of terminal hydroxyl groups. Hence, monomers are added 
to rings which form the three-dimensional structure. [8, p. 102, 109, 116] 
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In reactions (2) and (3), the silica particles are formed by polymerization of the mono-
mer. For hydrogel formation, two additional steps are required, which are the growth of 
the particles and then attaching of particles to form chains [8, p. 100]. As mentioned, 
silica only forms oligomers and does not polymerize linearly. It takes approximately 20-
50 silica molecules to form a particle which is approximately 2-5 nm in diameter. The 
particles are constantly formed in liquid and moved by thermal radiation. The particles 
hit each other and aggregate [53]. In addition, small particles below some critical value 
redissolve due to high solubility and allow larger particles above that radius to grow 
even more. This causes size distribution of particles in the solution and the phenomenon 
is called Ostawald ripening [69]. The silica backbone is formed as aggregated particles 
form clusters [64]. The aggregation continues and formation of branched structures or 
clusters goes on until a gel is formed [71]. Gel-point refers to the point where elastic 
properties start to dominate: this can be observed in rheological measurements [26]. The 
process is presented in figure 7.  
 
Figure 7. Sol-gel process of silica. The process B particles only grow with decrease in 
number. Considering this study, the process goes as process A and particles aggregate. 
[8, p. 102] 
The resulting structure can be described as fractal: the structure is formed by random 
condensation and aggregation. Aggregation typically leads to the formation of clusters 
with highly branched fractal flocs [50]. The microstructure of silica hydrogel can be 
further characterized with three characteristics which are the fractal dimension (D), the 
average cluster size (Rg) and the mean diameter of primary particles constituting the 
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structure (a). The fractal dimension thus describes the mass distribution in the volume. 
[70] 
The microstructure parameters may be altered by changing silica concentration or pH-
value of the polymerization process. Polymerization can be divided into pH domains 
(figure 8).  
 
Figure 8. pH dependence of silica polymerization. In pH=2, silica is metastable and in 
approximately pH=6, the maximum aggregation speed is reached. [8, p. 104] 
In pH 2, silica appears to be metastable and the reaction proceeds very slowly. This is 
because both the point of zero charge and the isoelectric point where electric mobility of 
silica particles is zero are both in pH level 1-3 [8, p. 103‒104]. At the isoelectric point, 
the interaction of silica species is very weakly attractive [72]. After pH 2, aggregation 
starts to proceed rapidly and reaches the maximum speed at approximately pH 6. After 
pH 7, growth occurs as monomer addition to more condensed particles, instead of ag-
gregation and condensed particles are likely to be ionized. [8, p. 103–105] 
The effect of increasing pH for the microstructure is shown in figure 9.  
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Figure 9. Effect on pH to the cluster formation. Situation A and B represent low pH 
values in which parameter a keeps approximately constant. Parameter a then increases 
with pH (situations C, D). Situation C represents the pH value of approximately 6 
where condensation proceeds rapidly. [70] 
As pH increases, the radius of elementary particles increases. Thus, smaller and denser 
structure having low D and Rg are obtained at low pH. Low electrostatic repulsion al-
lows small particles to form a dense structure. As particle size grows, surface charges 
increase and cause more open structure with increasing Rg. If pH rises even more, 
strong electrostatic repulsion causes again more open structure. [70] 
The rate of condensation reaction significantly increases as pH increases. However, 
electrostatic repulsion only slightly increases with pH. Thus, at pH 6, the frequency of 
particle collisions significantly rises. This increases the number of incipient clusters and 
decreases the average number of particles forming the primary structure. This results in 
low D and Rg at pH values near pH 6. [70] In addition, at higher concentrations, particle 
crowding produces increased probability of collision between particles and thus the 
polymerization proceeds faster [50]. 
Silica concentration has a clear effect on resulting hydrogel structure. The R-value indi-
cates the amount of water in the hydrogel structure.  Low R-values yield weakly 
branched, “polymeric” sols. High R-values indicate higher amount of water and yield to 
highly condensed, particulate sols. High R-values promote hydrolysis and the reaction 
may go into completion. A fully hydrolyzed monomer is tetrafunctional and has thus 
two reactive hydroxyl groups which leads to branched structure upon polymerization. 
With low R-values, hydrolysis is not complete and fewer reactive groups are present in 
the structure and thus only little branching is present. However, as R-value is increased 
and while maintaining a constant solvent to silicate ratio, the concentration of silicate 
reduces which increases the time for sol to form a gel. As R-value is lowered, more re-
active species (silica molecules) are present in the sol and the frequency of particle col-
lisions rises. [62, p. 5‒6, 112, 126][70] 
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In polymer composites, the interplay between filler and matrix often results in nuclea-
tion [73]. In sol-gel processing, micro- and nanoparticles have been studied to provide a 
heterogeneous seed of nucleation and speed up the structure formation [9, p. 479]. Here, 
in silica-silica composites, the microparticles act as nucleation seeds and gelation pro-
ceeds more rapidly as microparticle concentration (Cmp) is increased.  
 Aging of the composite 
Although silica composites seem stable after gel formation, chemical activity continues 
inside the composite. Aging refers here to the processes of structural change and change 
of properties after gelation or in other words after the gel-point has been reached [8, p. 
9]. The driving force for structure transformation can be derived from entropy of the 
structures [67, p. 603]. The structure of silica nanoaggregates is rigid. Hence, in order to 
decrease entropy, gradual dissolution at the highest places of entropy and depositing 
dissolved monomers to places with lower entropy increases the solubility and structure 
reorganization [67, p. 603]. Processes that occur after gelation can be divided into three 
categories: polymerization, coarsening and phase transformation [8, p. 358]. 
In polymerization of silica, condensation continues after gelation due to labile hydroxyl 
groups which will eventually stiffen the network. Condensation may continue for 
months after gelation and the rate of reaction is dependent of pH, temperature and con-
densation. It has been observed that G’-value, which increases as new bonds by conden-
sation of hydroxyl-groups are formed, rises for longer time as R-value is decreased. 
This is due to higher R-values being more completely hydrolyzed and thus the possible 
stiffening occurs faster.  Another phenomenon that may be caused by condensation is 
syneresis or shrinkage of the gel network, resulting in release of water from the pores. 
Syneresis may cause cluster formation which in turn causes liquid areas in the gel. Ag-
ing may also result in further hydrolysis or in reverse reaction which is re-esterification. 
Re-esterfication can be prevented by introducing excess water in the structure. Coarsen-
ing is a dissolution process driven by differences in solubility. It causes smaller particles 
to dissolve and reprecipitate. The average pore size increases and necks are growing 
larger between particles (figure 10). [8, p. 358‒362, 389] 
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Figure 10. Dissolution of particles. The dissolution will result in larger necks between 
particles (presented as the black line) and thus stiffen the network. [62, p. 36] 
The final category of aging is phase transformations. Segregation of liquid in two or 
more phases may occur. [8, p. 364] 
Thus, aging has significant effects on the composite properties. Aging of the composite 
can be accelerated by high pH values or temperatures and the presence of fluorine ani-
ons [67, p. 603]. Fluorine anions catalyze the dissolution of silica and enhance the rate 
of aging and higher temperatures have been studied to rapidly increase the porosity of 
silica. High pH values accelerate solubility and rate of dissolution of silica. In addition, 
water content has an important role in aging. Organic liquids can retard aging by inhib-
iting condensation reactions and adsorbing silanol groups. [8, p. 364‒368] 
2.4 Silica in controlled drug delivery 
The main objective of both drug delivery and drug formulation is to provide efficient 
drug administration at a therapeutic concentration to a specific site of action [74, p. 58]. 
Drug substances are rarely administered at their natural state: they require protection 
and carriers to achieve the benefits for a patient [75, p. 9]. Thus, for achieving better 
therapeutic effect of a drug, it is not always necessary to increase the drug concentration 
but to rather develop an optimal drug delivery system [76, p. 24]. Controlled release 
systems aim to protect the drug from premature elimination, assist the drug to pass 
physiological barriers and to target the drug the desired area with reduced frequency of 
administration [1]. 
Compared to conventional drug delivery systems, for example tablets and capsules, con-
trolled release systems differ in the rate of release. Conventional drug delivery systems 
cause bursts of drug.  These variations may cause toxic plasma drug levels or result in 
poor effectiveness. Most controlled release systems aim to maintain a constant drug 
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level in the bloodstream after the rapid concentration increase in the beginning that is on 
the effective range. [2]  
 Silica in biological systems 
Silica has been studied in several applications in biomedical field, for example bone-
repairing devices and drug delivery systems [77]. During the last few decades, silica has 
been used for both soft and hard tissue regeneration [84.] Applications of amorphous 
silica do not restrict to biomedical applications: synthetic amorphous silica has been 
utilized in the manufacture of products such as paints, cosmetics, and food as additives 
and fillers [78]. 
Biocompatibility of silica is greatly dependent on the microstructure. Inhalation of crys-
talline silica has been studied to cause an inflammatory reaction and additionally, chron-
ic exposure leads to lung fibrosis and can progress into silicosis [78]. In addition, crys-
talline silica has been studied to induce lung cancer [79]. Toxicity of amorphous silica 
has raised some controversial evaluations although generally it is considered non-toxic 
[64][79]. 
In case of silica nanoparticles, toxic effect on cells rests upon cell type and cell line 
[79]. Macrophages have been studied to display sensitivity to amorphous silica nanopar-
ticles, which relates to ability for phagocytosis [78]. However, nanoparticle size also 
influences the cytotoxicity since the size affects to cellular uptake [78][79]. Biocompat-
ibility of biodegradable silica with white blood cells has been studied by Puskala. The 
silica sol and the silica hydrogel has been studied not to activate the white blood cells 
but to inhibit their activation. Thus, combining silica microparticles and silica hydrogel, 
an improved biocompatibility compared to plain microparticles can be achieved. [80]  
 Principles of controlled drug release 
Practically, most controlled release systems aim at achieving the zero-order release pro-
file with constant drug concentration in the bloodstream. However, a rapid increase of 
plasma drug level before it reaches a stable profile is present in most of the controlled 
release systems. This can be referred as a burst in drug release. In injectable hydrogel 
systems, drug bursts can be caused by unsuccessful encapsulation of the drug since pol-
ymer precursors do not set immediately. Other possible reasons in hydrogel systems are 
processing conditions, sample geometry, host and drug interaction and surface charac-
teristics of the host material. [2] Preparation processes with sudden phase transfor-
mations such as spray-drying may cause relatively large drug amounts to concentrate 
near the matrix surface [26]. Drug bursts may have negative effects such as local or sys-
temic toxicity [2]. However, drug bursts might be beneficial in some cases. Some con-
trolled delivery systems aim at variable release in which doses are intentionally not 
identical, for example in the treatment of hypertension. Still, the systems are more diffi-
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cult to develop [81, p. 34–35]. Bursts can be controlled to some extent such as by chem-
ical surface or pore size modifications [26]. 
There are several routes of administration for drugs and also several dosage forms 
available [75, p. 14–15]. Parenterally administered drugs are injected through a needle 
to various sites and to various depths. Parenteral administration aims to avoid the physi-
cal and enzymatic degradation of drugs before they reach their target site [74, p. 322]. 
Three main routes in parenteral administration are subcutaneous injection beneath the 
skin, intramuscular injections into muscle and intravenous injections into veins. Another 
more specific example is an intraocular injection into the eye. Drugs in parenteral ad-
ministration are usually either in a form of a solution or a suspension. Suspensions need 
to dissolve before the drug can be absorbed and therefore produce a response slower 
than solutions. [75, p. 20] 
 For parenteral administration, injectability or ministration via a surgical administration 
apparatus, for example a needle, a catheter or a combination of these is necessary [26]. 
Subcutaneous injection is usually performed through a 23–26 G needle, even finer nee-
dle is mostly applicable [55][82] and intraocular injection through a 27–31 G needle 
[83]. The finer the needle, the more comfortable it is to a patient and less tissue damage 
is caused. For sensitive tissues, such as the eye, a fine needle is necessary.  However, a 
fine needle sets a challenge to the injectability of the product. The finer a needle is, the 
more force is needed to push out the injectable product. [62] Thus, there must be a bal-
ance between injectability, tissue damage and pain level of the injection. 
There are several mechanisms how drug release to the body is controlled, as mentioned 
before. However, with silica-silica microparticles and encapsulated drugs, erosion medi-
tated by dissolution is the main mechanism and will be the only one discussed here 
[33][51]. Dissolution controlled release systems have drugs coated or encapsulated in-
side of slowly dissolving matrices, referred as monolithic system or membranes and 
reservoir system, respectively [1]. Dissolution involves transfer of the solid drug to the 
surrounding medium. The medium may be tissue, water or polymer. Solubility of the 
drug in a medium is defined as the concentration of the drug in the medium at saturation 
point. Solubility decreases as melting point of the drug increases and is thus a thermo-
dynamic property. Hence, dissolution rate is dependent on solubility and particle size 
and is a kinetic property.  [84, p. 30] With monolithic systems, the drug aggregates are 
distributed throughout the polymer matrices and dissolve when the matrix dissolves. In 
reservoir systems, the membranes have different dissolution rates and release the drug at 
different times. It is important to notice that controlled release mechanisms do not work 
only separately. The system is practically never dependent on only one mechanism but 
they overlap or are a combination of several. They may also dominate other mechanism. 
[1]  
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 Silica degradation and drug release 
Biocompatibility and degradability of sol-gel derived silica matrices as well as their 
tailorable properties make them attractive as drug delivery systems [76]. In addition, 
composite hydrogel delivery systems have attracted notable attention in advanced drug 
delivery, although some challenges such as accurate mathematical modelling are yet to 
be solved [85]. 
The release of drugs from amorphous silica microparticles is mainly governed by silica 
degradation and bulk erosion meditated by dissolution [18][64][86]. Diffusion of drug 
molecules has not been shown to be significant since the silica microparticles are dense 
enough to prohibit it [18][33]. Degradation of the matrix is governed by hydrolysis of 
siloxane bonds through the gel network [88]. It has been shown that in vivo silica dis-
solves by hydrolysis into body fluids as silicic acid without any additional steps. The 
silicic acid is removed mainly through urine [33]87][88]. However, biodegradable sys-
tems are not usually following purely ideal erosion models but are a combination of 
bulk and surface erosion models [33][88]. In addition, the structural variability of amor-
phous silica also makes it difficult to establish the accurate mechanistic models of disso-
lution [89]. It should also be noted that degradation or molecular breakdown of the ma-
trix is governed by the chemical composition and morphology as well as environmental 
conditions and device properties which should be considered [20, p. 177]. 
Usually, surface eroding thin polymers are following zero-order kinetics. It is possible 
to achieve zero-order kinetics with bulk-erosion with suitable matrix properties such as 
water and drug diffusion and polymer swelling [88]. Silica microparticles have been 
found to follow zero-order release [72]. This is because the solubility of silica in aque-
ous solution is low. Silica does not dissolve in silica saturated conditions. As silica mi-
croparticle pores are introduced to aqueous solution, local saturation occurs fast.  This 
limits dissolution rate inside the pores slow. [26][33][86] Some variation can be ob-
served in the release results which is shown most obviously in the initial burst. The 
composite structure has been observed in rheological studies to integrate as saturated 
silicic acid in the pores and presence of nanoparticles enhance the condensation on the 
microparticle surface. The effect of the integrated structure is likely to be strongest at 
the beginning of dissolution. Integrated structures make diffusion paths longer which in 
turn affects to the degradation of silica. [26]  
Microencapsulation techniques are not suitable for all polymers and drugs. The ad-
vantage of spray-drying is that drug loss is not a major issue since it involves gas in 
particle dispersion, not solvent. However, controlling the capsulation is difficult. Fur-
thermore, uncoated drug might occur. [20, p. 188] The drug burst effect occurs if encap-
sulation is unsuccessful [33]. 
26 
There are two ways to control the release of drugs from silica particles, either by con-
trolling the dissolution rate or the degradation of silica. The dissolution of silica has 
been studied to be relatively easy to control by adjusting some conventional sol-gel pa-
rameters: R-value, amount of solvent, catalyst concentration and the process parameters, 
for example aging and drying [87]. An increase in the R-value yields to increasing 
speciﬁc surface area, which also partly controls the release of drugs. Decreasing R-value 
has been observed to decrease the release rate with silica xerogels, which have more 
condensed structures [88]. 
 Composite formulations for low microparticle concentra-
tions 
Drug formulation and medical device development have many variables affecting to the 
functionality of the product. Response to drugs may vary between humans [10]. Gener-
ally, drug dosing and dosages are parameters that can be altered. Size of the patient is 
one of the main factors affecting drug dosing, although calculations of doses might be 
more difficult in case of obese patients [11]. This may cause problems for example in 
animal studies. The required dose for a small animal is significantly less than for a hu-
man.  
However, it is evident that the properties of the silica-silica composite are dependent on 
the microparticle concentration [50]. Thus, decreasing the microparticle concentration 
leads to weakening mechanical properties but more importantly slower gelation as mi-
croparticles serve as nucleating agents [73][9, p. 479]. Sedimentation of microparticles 
will occur if the viscosity of the sol does not rise to an adequate level to prevent particle 
motion quickly enough [6]. As was mentioned in chapter 2.2.3, reducing microparticle 
concentration decreases the ability of the composite to withstand shear stresses. This 
may lead to phase separation in injection.   
A possible solution to compensate the decreasing microparticle concentration is to low-
er the hydrogel R-value. Lowering the R-value reduces the amount of water in hydrogel 
structure and thus improves mechanical properties of the gel and could possibly stabi-
lize the microparticles. [8, p. 126][12] 
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3. EXPERIMENTAL SECTION 
3.1 Materials 
All used silica hydrogels were synthetized during the study whereas some spray-dried 
microparticles were provided by DelSiTech (Finland) and others were spray-dried dur-
ing the study. All microparticles were placebos: no drugs were encapsulated within the 
microparticles.  
 Sol-gel derived silica hydrogels 
The silica sols were prepared from deionized water, 0.1 M hydrochloric acid (Titripur®, 
Merck Millipore) reagent grade, and 98% reagent grade tetraethoxysilane (TEOS, Sig-
ma-Aldrich® USA). pH of the sols was adjusted with 0.1 M sodium hydroxide (NaOH, 
Titripur® reagent grade, Merck Millipore) and deionized water was produced with a 
MILLI-Q Academic (USA) water purification system. The sol-gel process is described 
in chapter 3.2.1.  
 Silica microparticles 
Microparticles were manufactured by spray-drying of silica sol. Silica sol reagents were 
the same as listed in previous chapter. In addition ethanol ETAX A of 94% reagent 
grade (Altia, Finland) was used in dilution of the sol. Spray-drying was conducted with 
Büchi B-280 (Switzerland) and Büchi B-191 (Switzerland). The process parameters are 
presented in table 1.  
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Table 1. Process parameters of spray-dried batches. RT indicates room temperature 
and RH room humidity. 
Date Spray-
drier 
Inlet 
(°C) 
Outlet 
(°C) 
Aspirator 
(m3/h) 
Atomization 
(l/h) 
Pump 
(%) 
RT 
(°C) 
RH 
(%) 
6.6.17 Büchi 
B-280 
120 93‒96 35 670 25 - 41 
22.6.17 Büchi 
B-191 
120 66‒68 35 700  25 22.5 40 
26.6.17 Büchi  
B-191 
120 93‒96 35 700 25 22.5 47 
 
Particle size distribution (PDS) was measured for the three used batches by laser dif-
fractometry by using Sympatec Helos H2370 laser diffraction apparatus (Sympatec 
GmbH, Germany) (table 2). 
Table 2. Size distributions of microparticle batches used in the study. First batch 
(23.8.16) was provided by DelSiTech Ltd and not spray-dried during the study. 
Spay-drying 
date 
Formulation D10 (μm) D50 (μm) D90 (μm) 
23.8.16 R5-50 2.09 7.44 18.75 
6.6.17 R5-50 2.08  5.14 11.78 
22.6.17 R5-50 1.80 3.90 7.59 
26.6.17 R5-50 1.69 4.34 11.54 
 
The first batch (23.8.2016) was provided by DelSiTech and the particle size distribution 
was not measured at the same time as of other batches. 
 Syringes and needles 
The silica-silica composites were prepared at DelSiTech. Samples that were not stored 
for longer period than 24 hours in room temperature were prepared intp 1 ml plastic 
syringes supplied by Terumo or 1 ml plastic syringes supplied by BD (USA). Stored 
samples of hydrogels and a sample (R150, Cmp=0.3) stored for 2 weeks were prepared 
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into Plajex™ 1 ml COP plastic syringes (Terumo, Japan). Samples for shelf-life studies 
(R=150, Cmp=0.3 and 0.4 g/ml) were prepared into 1 ml plastic Gx RTF® ClearJect® 
(Gerresheimer, Germany). 
The composite was filled into syringes. All syringes could be fitted with separately sup-
plied hypodermic needles having a needle gauge 27 G (0.4 x 20 mm) where the first 
number refers to outside diameter and the latter to the length of the needle. The needles 
(Neolus™) were supplied by Terumo (Japan).  
3.2 Methods 
The goal of the study was to investigate formulations with low microparticle concentra-
tion (Cmp< 0.5 g/ml) and low hydrogel R-values (R < 300). Requirements for a success-
ful formulation were that it is homogeneous, meaning evenly distributed microparticles 
in the hydrogel matrix with no distinct separation of the phases, injectable through a 27 
G needle and maintains its viscoelastic properties for 3 months. Several formulations 
with R ≤ 400 and Cmp=0.1g/ml‒0.4 g/ml were examined. Thus, the study consisted of 
many phases as presented in figure 11. 
 
Figure 11. A process chart of the study. The study began by selecting suitable hydro-
gels, proceeded to iteration of suitable formulations and the final step was to evaluate 
some formulations in shelf-life studies.  
The four phases of the study were the following:1) hydrogel selection, 2) study of the 
influence of variable microparticle concentrations on composite prepared with first 
method, 3) study of the influence of variable microparticle concentrations on composite 
prepared with second method and 4) the shelf-life study of two formulations, evaluated 
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with rheological and injection force studies. In hydrogel selection, hydrogels with only 
low R-values were studied. Firstly, a lower limit was set by preparing samples to be 
studied after 24-hours. Secondly, the lowest viable R-value at which the viscoelastic 
properties were still maintained was determined by storing three formulations for one 
and two weeks at +37°C. 
After hydrogel R-value iteration, composite iteration was carried out to determine suita-
ble formulations. Visual observation was conducted after stabilization of the samples 
(after 24 hours). If the composite was clearly heterogeneous, having two separated 
phases, it was photographed and no further studies were carried out. If homogenous 
formulations could be prepared, oscillatory measurements were conducted. One syringe 
was stored in +37°C for two weeks and compared to 24-hour sample to see if the com-
posite maintained its properties. From two formulations, storage samples were manufac-
tured for five time points (1, 14, 30, 60 and 90 days) to study the injectability and visco-
elastic properties as a function of time. The stored samples were sealed in aluminum foil 
pouches.  
Composite preparation was the main process in the study and consisted of two main 
procedures. Firstly, the sol was prepared by sol-gel method and secondly, the micropar-
ticles were weighed in a plastic container and sol was pipetted into the container. The 
mixture was stirred manually for 5 to 8 minutes to ensure homogeneity. The mixture 
was pipetted into plastic syringes and allowed to set in tube rotator for 24 hours. In ad-
dition to the composite preparation process, manufacturing of the silica microparticles 
was an additional process in the study.  
 Spray-drying of microparticles 
Preparation of microparticles began as in sol-gel method. First, deionized water, 0.1 M 
HCL and TEOS and stirred with a magnetic stirrer (1100 rpm) for 25 minutes and then 
ethanol was added to the solution. The sol was produced at a mole ratio of 5:0.002:1:45, 
respectively. After ethanol addition, pH was adjusted with 0.1 M NaOH to approximate-
ly 6.0. The microparticles were stored at room temperature in 50 ml plastic containers. 
The microparticles formulation (R5-50) was kept constant during the study. The first R-
value (R5) denotes the R-value of the initial sol, before addition of ethanol. Ethanol is 
used to dilute the sol to higher R-value, which is indicated in the latter value in the for-
mulation.  
 Sol-gel processing 
Several formulations of silica sols were prepared in the study, ranging from R-values 50 
to 400. The sols were prepared by adding deionized water, 0.1 M HCL and TEOS, at 
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mole ratios from 50:0.01:1 of R50 to 400:0.01:1 of R400. Approximately 20‒30 ml of 
sol was prepared at each time.  
The sol was stirred with a magnetic stirrer at 1000‒1100 rpm for 25 minutes in a sealed 
laboratory bottle at room temperature. Stirring was done in order to speed up hydrolysis 
and to ensure that it is complete. The object was to retain vigorous stirring, without 
splashing. Mixing was successful if the solution had only one phase in the end of stir-
ring. After stirring, pH of the sol was approximately 2 in which silica is metastable and 
the condensation proceeds very slowly.  pH of the sol was raised to 6.2 (±0.1) with 0,1 
M NaOH. The sol could be directly pipetted into a syringe to study only the hydrogel.  
 Composite preparation  
Composite preparation began after the sol was set to pH 6.2±0.1. At this point, conden-
sation proceeds rapidly [70] and aging of the sol was considered to begin. The aim was 
to use fresh sols which have not been allowed to age before further processing: for this 
reason, mixing of the sol with microparticles began immediately. Some experiments 
were conducted with aged sols which will be discussed in chapter 4.2.1. The composites 
were prepared with two alternative methods. 
In the first method, microparticles were weighed in a 50-ml plastic container. Micropar-
ticle mass concentrations (Cmp) of the prepared composites were 0.1 g/ml; 0.2 g/ml and 
0.3 g/ml. In addition, some stored samples were manufactured with Cmp= 0.4 g/ml. The 
sol was pipetted into the container with microparticles and the composite was mixed for 
approximately 5 to 8 minutes with 5 ml pipette head, to produce a homogenous mixture. 
Composite amount was at the beginning approximately 1 ml but the amount was in-
creased to 3 to 4 ml; to ensure facile stirring. Next, 0.8-1 ml of composite was filled into 
syringes and held in a tube rotator for 24 hours at 7 rpm to prevent microparticle sedi-
mentation before stabilization. Stabilization indicates the time after sedimentation of 
microparticles no longer occurs. 24 hours is calculated from the point a syringe is 
placed into the tube rotator as is all time-points in the study. The 24-hour time point was 
set based on Noppari’s studies [86] where it has been shown that a composite with for-
mulation R400 Cmp=1 g/ml stabilizes in 8 hours, indicating that 24 hours should be ade-
quate. Filling and placing a syringe into the tube rotator took approximately 3-5 
minutes.  
In the second method, the sol was prepared in the same way as in the first method and 
the pH was raised to 6.2±0.1. Microparticles were weighed in a 50 ml CELLSTAR® 
tube (Greiner Bio-One, Austria) and their total mass was weighed. Next, microparticles 
were washed with 20 ml of sol and the system was mixed with a Vortex mixer (Fischer 
Scientific, USA). The solution was centrifuged in 4000 rpm for 10 minutes and excess 
sol was removed with a pipette. Microparticles absorbed some sol which is why all sol 
could not be removed. Total mass of the container and its contents were weighed and 
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the volume of the absorbed sol was calculated. Next, more sol was added to obtain the 
desired microparticle concentration within the composite. The composite was then 
mixed manually with a 5 ml pipette head for 5 minutes and filled into 1 ml syringes. 
The syringes were placed in a tube rotator with 7 rpm and allowed to stabilize for 24 
hours. The studied formulations and preparation method are given in table 3. 
Table 3. Prepared composite formulations in the study and their preparation method. 
Number 1 or 2 indicate the manufacturing method (method 1 (1) or method 2 (2). A 
hyphen indicates that a sample was not prepared. 
R-value Cmp=0.1 g/ml Cmp=0.2 g/ml Cmp=0.3 g/ml Cmp=0.4 g/ml 
R125 1 1 1 - 
R150 1 1 1 1 
R200 - 1 1 - 
R250 - - 1 - 
R300 - 2 2 - 
R400 - 2 2 - 
 
Some formulations were chosen for shelf-life studies and the samples were studied with 
oscillatory and injection force measurements in five time points. Consequently, 20 sam-
ples of one formulation were prepared, so that four samples could be studied in each 
time point. Due to manual manufacturing of the syringes, the sol may have significantly 
aged as last samples were prepared. Thus, two identical batches of sol were prepared so 
only 10 samples were prepared from each batch of sol, to minimize the aging of the sol.  
 Rheological measurements 
Rheological measurements were conducted with ThermoHaake RS 300 (Germany) rota-
tional rheometer with a parallel-plate geometry HPP20 TC measuring geometry (D=20 
mm). Oscillatory measurements were conducted in controlled deformation and with two 
measuring settings. The storage sample for 14 days and the 24-hour reference sample 
were measured with 0.4 gap, deformation of 0.002 and frequency range of 0.01-10 Hz. 
The samples of the shelf-life study were measured with 1 mm gap, deformation of 0.001 
and frequency range of 0.1-10 Hz.  
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 Injection force measurements 
Injection force studies were conducted with Lloyd-Ametek LS100 Plus (USA) with a 
250 N load cell. Needle gauge was kept constant at 27 G. The measured machine exten-
sion was converted into amount of injected composite.   
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4. RESULTS AND DISCUSSION 
4.1 Hydrogel selection 
The study of silica hydrogels was conducted to determine a hydrogel with lowest possi-
ble R-value that could be utilized in composite preparation. Hydrogels with low R-
values have two characteristics that may prevent their use in composite preparation. 
Firstly, decreasing R-value increases the solid substance in the hydrogel and possibly 
weakens the injectability. In addition, microparticles further stiffen the composite and 
thus, if the hydrogel itself has low injectability, composite preparation would not be 
necessary. Secondly, decreasing R-value could result in continuous condensation reac-
tion and structural changes. [30, p. 368] 
 24-hour evaluation 
Preparation of the hydrogels began with R-values R50, R100 and R200. The 24-hours 
samples were evaluated by visual observation.  24 hours indicates time when the sample 
was left to gel and the moment of examination.  Surface properties and structure of the 
gel were evaluated by visual observation. Table 5 shows the terms that were used to 
characterize the samples. 
Table 5. Characterization of hydrogels. Surface properties, structure and injected 
product were evaluated based on presented characterizations.  
Surface properties Structure 
Glossy Solid gel; not letting liquid out 
Matte Weak gel; some liquid separat-
ed 
Grainy Liquid-like 
Smooth  
 
R100 could be described as glossy, grainy and solid gel. R200 was also glossy, but rep-
resented a smooth weak gel: the structure was runny. R50 was considerably different 
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than R100 and R200: the hydrogel was matt and grainy. In addition, gelation occurred 
fast, within first 10 minutes with 10 ml of R50 which could be problematic in composite 
preparation. Therefore, R50 was ruled out of the study and replaced with R80 in further 
studies. 
 Stored hydrogel samples 
Samples of R80, R100 and R150 were prepared for storage in +37°C and the results are 
tabularized in table 6. 
Table 6. Characterization of hydrogel samples stored for two weeks. The injections 
were performed through a 27 G-needle manually. Injectability is described as poor, ok 
or good, based on the required force to push the plunger.  
 1 week  2 weeks  
R-value Injectability Visual observation Injectability Visual observation 
R80 
 
Poor, few 
droplets 
Matt, grainy, solid 
gel. Separation of 
liquid. 
Poor, few 
droplets 
Matt, grainy, solid 
gel,  
R100 Good 
 
Glossy, grainy, solid 
gel. 
Poor Glossy, grainy, solid 
gel. Separation of 
liquid. 
R150 Good Glossy, smooth, 
weak gel 
Good Glossy, smooth, weak 
gel 
 
Both R80 and R100 went through structural changes that altered their appearance and 
injectability. At two weeks’ time point, both R100 and R80 were notably “dry” and 
came out of the syringe as separate pieces instead of a uniform gel.  R150 did not 
change its properties dramatically in visual observation. Thus, R100 and R80 were ruled 
out of the studies. However, the lowest R-value in the composite was set to R125 be-
cause R150 had no dramatic structural changes while the changes of R100 were not as 
obvious as of R80.  
4.2 Iteration of homogeneous composite formulations 
Preparation of composites with different R-values and microparticle concentrations was 
conducted to find out homogeneous formulations that maintain their viscoelastic proper-
ties in short time storage test. These samples could be studied further in shelf-life stud-
ies for longer storage period. 
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 Short term stability samples 
The 24-hour samples were the first evaluation method of composites. The main goal 
was to study whether visually homogenous samples could be prepared from certain 
formulations. The results are reported as sample photograph. The first samples were 
prepared with preparation method 1, utilizing fresh sol directly pipetted to microparti-
cles Figure 12 presents the samples of R125. 
 
Figure 12. Samples of R125. From the left, the samples present different microparticle 
concentrations:  0.1 g/ml (A), 0.2 g/ml (B) and 0.3 g/ml (C). Circled areas indicate sep-
aration in a sample.  
The samples showed clearly inhomogeneous structure. The circled areas in Figure 12 
indicate areas with only hydrogel and no microparticles. That could be seen as an obvi-
ous change of color: a homogeneous syringe would be evenly white. In all samples, a 
clear sedimentation of microparticles occurred. The hydrogel area was smallest in sam-
ple with Cmp=0.3 g/ml and slightly smaller in sample with Cmp=0.2 g/ml than in sample 
with Cmp=0.1 g/ml which is logical since the lowest concentration has the lowest 
amount of microparticles and also pack in a smaller volume. The hydrogel areas were 
either on top or bottom of the syringe which indicates the effect of rotation pushing the 
microparticles on either end. The syringes where randomly placed in the tube rotator 
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either pointing up or down and the microparticles were packed also randomly on either 
end of the syringe, regardless of the syringe position.  
Increasing R-value showed more homogeneous samples at the highest applied concen-
tration. Samples of R150 are presented in figure 13.  
 
Figure 13. Samples of R150. From the left, the samples present different microparticle 
concentrations: 0.1 g/ml (A), 0.2 g/ml (B) and 0.3 g/ml (C). Circles areas indicate hy-
drogel separation. 
With these samples, a significant difference between different microparticle concentra-
tions could be observed. A sample with Cmp=0.1 g/ml was mostly consisting of hydro-
gel and a small volume of packed microparticles near the piston. Again, sample with 
Cmp= 0.2 g/ml had considerably smaller volume of separated hydrogel but the sample 
was still heterogeneous. On the other hand, a sample with Cmp= 0.3 g/ml is visually ho-
mogenous. The color is uniform throughout the syringe area and, despite of a small sep-
arated area near the piston, the sample showed the most homogeneity of all prepared 
samples. A small separation was more likely to be caused by an air bubble or unsuc-
cessful filling than the material property.  
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Despite of a successful sample of R150, increasing the R-value even more did not im-
prove the homogeneity of the samples. Figure 14 shows the samples prepared of R200 
and R250. 
 
 
Figure 14. Samples of R200 and R250. From the left, the samples present different for-
mulations: R200 and Cmp=0.2 g/ml (A), R200 and Cmp=0.3 g/ml (B) and R250 and 
Cmp=0.3 g/ml (C). Circled areas indicate hydrogel separation.  
All samples were again heterogeneous. Samples with Cmp= 0.1 g/ml were not prepared 
because the concentration was not successful at lower R-values and an increasing R-
value would result in weaker gel with increased gelation time [8, p. 126][12]. Thus, 
R200 was prepared with Cmp=0.3 g/ml and 0.2 g/ml and R250 only with Cmp=0.3 g/ml. 
Samples of R200 were clearly heterogeneous with clear hydrogel area but the sample of 
R250 showed a different structure. The sample was heterogeneous but had small hydro-
gel areas all over the syringe. The pattern is similar to a marble surface: hydrogel areas 
and microparticle clusters formed a random pattern. In addition, as all studied samples 
were injected from the syringe without a needle, clear microparticle clusters could be 
observed in most of the samples.  
After the preparation with method 1, some samples were prepared with the alternative 
method 2. In this method, microparticles were prewetted with sol in order to stabilize 
 
 
 
39 
them and prevent them from sedimentation. The method was suggested by DelSiTech 
since it was used in microencapsulation. R-values of 300 and 400 were used in compo-
site preparation since R400 has been shown to maintain viscoelastic properties for 30 
days’ storage time. [86] Figure 15 shows samples prepared with R300. 
 
Figure 15. Samples of R300. From the left, Cmp=0.2 g/ml (A) and Cmp=0.3 g/ml (B). 
Circled areas indicate separated hydrogel. 
A sample with Cmp=0.2 g/ml was heterogeneous and separation had concentrated near 
the piston. The position indicated that an air bubble was trapped in the syringe. Howev-
er, hydrogel areas were also visible on other areas of the sample. Separation in sample 
with Cmp=0.3 g/ml was not as obvious but hydrogel areas were also present in the sy-
ringe. 
Samples with R400 were also prepared with the method 2. Respectively, the samples 
showed clear heterogenicity (figure 16). 
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Figure 16. Samples of R400. From the left, Cmp=0.2 g/ml (A) and Cmp=0.3 g/ml (B). 
Circled areas indicate hydrogel separation.  
Both samples had separated hydrogel areas, as the samples of R300. 
The reason why sedimentation of microparticles occurred can be derived from the mi-
crostructure and rheology. The reason why the composite is manually mixed for a cer-
tain time is that viscosity drops as shearing takes place in the material, allowing parti-
cles to be homogenously mixed to the sol [46, p. 21]. As mixing is ended, the original 
structure is restored [6][7] which means also the same viscosity value as before mixing. 
Sedimentation occurred in almost all samples, indicating also that with lowered R-value 
condensation does not proceed quickly enough to raise viscosity to an adequate level 
[6]. Gravitation affects the microparticles [53] and lack of viscosity causes the sedimen-
tation. This confirms that microparticles act as seeds of nucleation [9, p. 479]. With 
higher microparticle concentrations, gelation proceeds more quickly and prevents parti-
cle sedimentation. 
As already studied in DelSiTech, aging of the sol – meaning the waiting time before sol 
is mixed to the microparticles as pH is risen to 6.2 ‒ was beneficial in composite prepa-
ration. Effect of aging was studied with some formulations, such as R150 Cmp=0.1 g/ml 
and R200 Cmp=0.3 g/ml (figure 17).  
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Figure 17. Samples prepared with aged sol. Figure A: R150 Cmp=0.1 g/ml, aged in 
room temperature for 10 minutes before adding microparticles. Figure B: R200 
Cmp=0.3 g/ml, aged for 60 minutes in room temperature before adding microparticles. 
Visually homogeneous samples could be conducted even with Cmp=0,1 g/ml. However, 
the optimum aging time is dependent on the sol volume and R-value and is thus difficult 
to predict.  
As a conclusion, preparing homogeneous samples from fresh sols was proven to be 
challenging. The samples were very sensitive and for example increasing rotation speed 
resulted in heavy sedimentation of microparticles. However, it must be noted that exper-
iments were conducted with only one microparticle formulation and the effects of mi-
croparticle size, geometry or encapsulated drugs were not evaluated.  
 Samples stored for two weeks 
In this study, it was essential to evaluate the shelf-life of the homogeneous formulations. 
The prefilled syringes are designed to be “ready-to-use” products which can be injected 
at desired time after storage. Thus, it is important that the composite maintains its vis-
coelastic properties. One sample of R150 Cmp=0.3 g/ml was prepared in storage in 
+37°C and compared to a 24 h-sample. If remarkable changes in the structure would 
A B 
42 
already occur in two weeks, it would be useless to prepare several samples for various 
time points for 3 months’ storage. The G’ and G’’ values obtained from oscillation 
measurements could be compared between a 24-hour sample and a two week-sample 
(figure 18). 
 
Figure 18. The effect of two weeks’ storage on R150 Cmp=0.3 g/ml. The G’- and G’’-
values are presented for a sample stored for 24 hours in room temperature and for a 
sample stored for two weeks at +37°C. The plotted values are averages of three repli-
cate measurements. 
G’ values did not significantly increase indicating that no remarkable condensation has 
occurred within two weeks’ time [8, p. 389]. In ideal case of a homogeneous hydrogel, 
the G’ and G’’ diagrams would be almost horizontal. Both samples thus indicated some 
inhomogeneity. However, it must also be noted that there were only three replicate 
measurements and due to the sensitivity of the material and difficult insertion between 
the plates in measurements, absolute repeatability is difficult to obtain. 
4.3 Shelf-life of R150 
Since R150 Cmp=0.3 g/ml possessed no significant structural changes in two weeks, 
samples for storage were manufactured to evaluate the evolution of composite injecta-
bility and structure within 3 months. The samples were visually evaluated. Since the 
formulation R150 Cmp=0,3 g/ml showed inhomogeneity in samples stored for 24 hours 
and 2 weeks, additional samples for storage were prepared on R150 Cmp=0.4 g/ml. The 
decision was also supported by the fact that there were no other successful formulations 
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for shelf life studies and although the most preferable microparticle concentrations were 
0.1 g/ml, 0.2 g/ml and 0.3 g/ml, the final limit was set as Cmp < 0.5 g/ml. Figure 19 
shows the prepared samples of R150 Cmp=0.3 g/ml and 0.4 g/ml. 
 
Figure 19. Samples of R150 for shelf-life studies. Figure A presents samples stabilized 
for 24 hours in room temperature with Cmp=0.3 g/ml and figure B samples with 0.4 
g/ml. 
The prepared samples with Cmp=0.4 g/ml were visually more homogenous than Cmp=0.3 
g/ml. Separated hydrogel areas could be observed in most of the syringes, while some 
were relatively homogeneous. This also indicates that obtaining identical samples of the 
formulation is challenging although the filling method, sol age and preparation method 
were kept constant.  
 
A 
B 
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 Viscoelasticity of the stored samples 
In order to investigate the structure of the composite and its homogeneity, rheological 
measurements were conducted in small angle oscillatory shear. Figure 20 shows the 
results in 0.1 Hz. G’- and G’’-values are plotted in each time point. The results are 
shown in two different frequencies, 0.1 Hz and 10 Hz. These frequencies are the starting 
and ending frequency in frequency sweep measurements. 
 
Figure 20. G’- and G’’-values in 14, 30, 60 and 90 in days’ time points measured in 0.1 
Hz. The plotted values are averages of six replicate measurements.  
G’-values of samples with Cmp=0.3 g/ml did not possess significant differences in 90 
days. However, tan(δ) has risen, indicating higher G’’-values. This again suggests struc-
tural changes in the composite. As G’’-values exceed the G’-values (tan(δ)>1) viscous 
properties are dominating in the composite, suggesting liquid-like behavior. [62, p. 359, 
363]  
Samples with Cmp=0.3 g/ml possessed higher G’-values in 30 and 60 days’ time points 
than samples with Cmp=0.4 g/ml although in particulate composites the particles should 
stiffen the material. [50] Samples with Cmp=0.3 g/ml were observed to let out liquid as 
they were compressed between the plates, but the same phenomenon was not observed 
with samples with Cmp=0.4 g/ml. Thus, G’-values are higher since some amount of liq-
uid is leached out of the hydrogel structure.  
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In 90 days, significant structural changes were observed in some of the samples. In case 
of Cmp=0.4 g/ml, the G’-values rise significantly in three months’ time point: G'-values 
had risen since some of the samples had turned into a monolith (figure 21). 
 
Figure 21. Some of three months’ samples possessed significant structural changes. 
Figure A is a sample with Cmp=0.4 g/ml and figure B is a sample with Cmp=0.3 g/ml. 
The samples have turned into shrunken, solid mass and some liquid has concentrated on 
the barrel walls. 
This phenomenon was observed in several syringes, 3/8 samples in total. Figure 21 
showed the most dramatic example of syneresis, the leakage of water from the pores 
and solidification of the composite with Cmp= 0.4 g/ml in 90 days’ time point. [62, 
p.359] This sample affects the G’-values significantly since in other syringes the phe-
nomenon is not as dramatic. In one sample with Cmp=0.3 g/ml and in one sample with 
Cmp=0.4 g/ml syneresis was shown as slight shrinkage of the composite and concentrat-
ed water in the barrel walls. 
 
A B 
46 
Figure 22 shows the results for 10 Hz which also indicated aging phenomena. 
 
Figure 22. G’- and G’’-values in 14, 30, 60 and 90 in days’ time points measured in 10 
Hz. The plotted values are averages of six replicate measurements. 
In 10 Hz, the G’-values showed more obvious increase in both formulations. The sam-
ples with Cmp=0.3 g/ml did not show an increase of tan(δ)-values in 90 days as in 0.1 
Hz. This suggests that in rest, the sample has liquid “pockets” and the viscous behavior 
is more prominent. As shearing takes place and the sample deforms, the pockets move 
and G’’-values decrease.  
Aging of the composite can be accelerated by temperature but also by rising pH-levels. 
Especially coarsening is strongly pH-dependent. [30, p. 364] The pH-values were 
measured from depots before filling into syringes at the manufacturing stage and in 90 
days’ time point (table 7).  
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Table 7. pH values of stored samples. pH was measured from non-aged microparticle/ 
sol mixture (stored for 0 days) and samples stored at +37°C for 90 days. 
R-value Cmp (g/ml) Batch Storage time (d) pH 
R150  0.3 1 0 6.0 
R150  0.3 2 0 6.0 
R150  0.4 1 0 5.9 
R150  0.4  2 0 6.0 
R150  0.3 1 90 5.8 
R150  0.3 2 90 5.8 
R150  0.4  1 90 5.7 
R150  0.4 2 90 5.7 
 
It is evident that the pH-values do not explain the structural changes: the values stayed 
within the same range.  
Overall, samples with Cmp=0.3 g/ml were visually more inhomogeneous than samples 
with Cmp=0.4 g/ml and let out liquid in injection. However, samples with Cmp=0,4 g/ml 
had more variation between replicate measurements. As a result, with R150 all samples 
did not maintain their viscoelastic properties for 90 days. Aging, especially syneresis 
was observed in both formulations. However, not all samples turned into monoliths and 
with Cmp=0.3 g/ml most samples did not alter significantly. Overall, 3/8 samples in 
three months’ time point had shrunk in to a solid mass and let out water from their 
structure. The result indicates some differences between the samples since not all sam-
ples possessed as dramatic structural changes despite they were identically prepared. 
The differences may arise from manufacturing of the syringes, for example successful-
ness of the filling.  However, this also indicates that the samples are prone to aging. 
Additionally, longer storage times may result in more structural changes in the compo-
site, as low R-value is utilized [62, p. 389]. 
 Injectability of the stored samples 
Injectability of the composites was studied through a 27 G-needle. A fine needle was 
selected since it is applicable even in intraocular injections [83]. The shear-thinning 
characteristic allows the composite to be injected through a fine needle [6][7] The re-
sults are given separately for both formulations and graphs plotted as the amount inject-
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ed out as a function of the applied force is presented in supplements (figures 23‒27). 
The results for samples with Cmp=0.3 g/ml are presented (table 8). 
Table 8. Injectability of R150 Cmp=0.3 g/ml samples. Injectability is presented as the 
amount of composite that was injected out of 1000 μl. Observations indicate whether all 
of the composite was injected out (successful) or not (blocked). 
Storage time (d) Amount injected out (μl)  Observations 
1  241  Blocked 
 267  Blocked 
14 477  Blocked 
 954  Successful  
30 858  Blocked 
 679  Blocked 
60 889  Successful 
 945  Successful 
90 363  Blocked 
 437  Blocked 
 
In most cases, injectability of the samples was poor: 5/10 syringes were blocked before 
half of the composite was injected out. In addition, 80‒100 N that can be considered as 
a rough estimation of the maximum finger pressing force for an adult was exceeded 
[57]. Only 3/10 injections were successful meaning the whole dose is injected out of the 
syringe. No trend could be observed between different batches. However, the injected 
amount of composite was notably smaller in 1 day and 90 days’ time point than in other 
time points. The poor injectability in 90 days was supported by rheological and visual 
observations: many samples had significantly solidified. The results in the 24 hours’ 
time point are more likely to be caused by the measuring technique. The measurements 
were manually stopped if the needle was blocked. In some occasions, microparticles 
may form bigger clusters at the syringe entry and block the syringe for few seconds 
[52]. This can be seen in injection force measurements as sudden force peaks. The inte-
grated structure may be broken down quickly and most probably the first measurements 
were stopped too early in case of such an obstruction.  
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Both samples in 60 days’ time point were successfully injected. The same phenomenon 
can be observed with Cmp=0.4 g/ml samples (table 9).  
Table 9. Injectability of R150 Cmp=0.4 g/ml samples. Injectability is presented as the 
amount of composite that was injected out of 1000 μl. Observations indicate whether all 
of the composite was injected out (successful) or not (blocked). 
Storage time (d) Amount injected out (μl) Observations 
1 700 Blocked 
 269 Blocked 
14 688 Blocked 
 589 Blocked 
30 632 Blocked 
 451 Blocked 
60 911 Successful 
  927 Successful 
90 902 Successful 
 427* Successful 
*The syringe was not filled to 1000 μl 
The explanation for the improved injectability can be derived from sample selection 
since no obvious trend of improved injectability of both formulations could be observed 
or supported from rheological studies. These differences may arise from aging. The 
samples were manufactured in two batches to minimize the aging time of the sol. How-
ever, it took approximately 3-5 minutes to fill a syringe and place in a tube rotator. This 
means that when five samples were manufactured, the last syringe was filled from a sol 
that had been aging for already 12-20 minutes. As was seen in figure 17A, already 10 
minutes of aging time improved the homogeneity of the syringe with formulation R150 
Cmp=0.1 g/ml.  
Overall, injectability of samples with Cmp=0.4 g/ml was also poor, although only 2/10 
samples were blocked before half of the composite was injected. This supports the visu-
al observation that samples with Cmp=0.3 g/ml are more heterogeneous than samples 
with Cmp=0.4 g/ml although more variation is seen in oscillatory measurements. A total 
of 4/10 samples were successfully injected, including one syringe that was not filled to 
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1000 μl. The results indicate that inhomogeneous structure is present in both formula-
tions and causes difficulties in injections.  
The results indicate that the material is not flowing consistently but phase separation 
occurs by filtration in the barrel. As the plunger is pushed in the syringe, the hydrogel 
matrix starts to flow more easily. If the material is heterogeneous, microparticles may 
form bigger clusters or be already packed close as hydrogel matrix flows. The integrated 
microparticles may cause a blockage at the barrel [52]. It is evident that the formula-
tions do not withstand the pressure as being injected through a fine needle. Based on the 
results of this study, lower R-values than R150 are not recommended for composite 
preparation. However, higher R-values would result in weaker mechanical properties of 
the matrix [12] and thus the ability to withstand the injection may decrease.  
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5. CONCLUSIONS 
The aim of this study was to examine if a formulation with lowered microparticle con-
centration could be successfully manufactured (Cmp < 0.5 g/ml). A successful formula-
tion was defined by three characteristics: the composite must be homogeneous, injecta-
ble through 27 G-needle and maintain its viscoelastic properties for three months. Low 
microparticle concentrations are required in animal testing since composites are formu-
lated for humans but they are first studied in animals. Since the lowered microparticle 
concentration weakens the mechanical properties of the composite and increases hetero-
geneity, R-value was also lowered, ranging from R50 to R400 in order to improve the 
mechanical properties of the matrix. 
At the beginning, an iteration of suitable R-values was conducted by visual observation 
of fresh hydrogel samples and those which had been stored in +37°C to enhance the 
aging process for one and two weeks. After the shelf-life study of R80, R100 and R200, 
both R80 and R100 had structural changes: in both formulations, the liquid was leached 
out of the hydrogel structure. The result was supported by self-injection studies through 
a 27 G-needle in which R100 and R80 showed poor injectability in 2 weeks’ time. As a 
conclusion, an R-value between R100 and R150 is acting as the lowest limit for a hy-
drogel that still maintains its structure or in other words remarkable condensation does 
not occur in two weeks’ time in +37 °C.  
Iteration of suitable formulations for shelf-life studies, ranging from R125‒R400 with 
Cmp=0.1‒0.4 g/ml, showed that a homogeneous sample with low microparticle concen-
trations was difficult to obtain. In most cases, sedimentation of the microparticles oc-
curred in 24 hours although a tube rotator was used during stabilization. Thus, lowered 
R-value does not sufficiently compensate the decreased microparticle concentration and 
viscosity does not rise to an adequate level to stabilize the microparticles. However, 
only one microparticle formulation was used in studies and the effect on size or shape 
was not investigated. The only formulation from which visually homogeneous samples 
could be prepared was R150 Cmp=0.3 g/ml. However, some visual inhomogeneity could 
be observed as several samples were manufactured for storage.  
Shelf-life studies of R150 Cmp=0.3;0.4 g/ml were conducted with five measuring points 
for three months. This was important since it was already clear with hydrogels that ag-
ing may induce significant structural changes that may destroy viscoelastic characteris-
tics of the composite. In oscillatory measurements, this phenomenon was proven: total 
of 3/8 samples had shrunk and released liquid from the pores after three months. Aging 
processes were evidently occurring in both formulations and rising G’-values could be 
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observed with Cmp=0.4 g/ml. With many samples of Cmp=0.3 g/ml, liquid was separated 
in the syringe and the G’’-values had increased. However, some samples had less dra-
matic structural changes and thus variation between identical measurements was in-
creased during time. Injection force studies showed poor injectability of the formula-
tions:  Only 2/10 injections with Cmp=0.3 g/ml and 4/10 injections with Cmp=0.4 g/ml 
were successful. In addition, the results showed that there was notable variation between 
the samples. This in turn indicates that some samples had been prepared from aged sol 
which improves the homogeneity. As a result, R150 is possibly near the lowest limit of 
usable R-values in composite preparation and no lower R-value is recommended. Some 
of the samples did not maintain the viscoelastic properties and longer storage time could 
enhance the structural changes.  
Aging of the sol evidently improves the homogeneity of the sols. From fresh sols, a ho-
mogeneous formulation that keeps the viscoelastic properties was not successfully man-
ufactured. Thus, for Cmp<0.5 g/ml another approach is required. Since the aging times 
are difficult to predict for different volumes, a successful formulation could be manu-
factured by adding the microparticles to an already formed hydrogel with capability to 
avoid microparticle sedimentation. The hydrogel exhibits shear-thinning characteristics 
which may be used to mix the microparticles within the gel (exceeded the gel-point). A 
system such as dual-barrel syringe could potentially offer a solution, by adding only sol 
to other barrel and sol with microparticles to another. Extrusion would provide mixing 
of both barrel content to obtain a composite with light concentration. A dual-barrel sy-
ringe can be used to dispense or inject fluids [90]. However, hydrogels with R-values 
lower than 150 are not recommended in composite preparation since aging processes 
were clearly observed with R150.  Another approach to obtain homogeneous formula-
tions is to use additives in the hydrogel network to stabilize the microparticles and to 
obtain homogenous structure. Glycerol has been studied with silica aerogels to increase 
the gelling time and to cause an increase in G’-values [91]. The effect of glycerol has 
been studied to be beneficial in PVA hydrogel, by improving physical properties [92]. 
Another polyol additive could also be used. Linseed oil based polyol has been studied as 
a potential crosslinking agent that leads to the formation of interpenetrating networks 
and also introducing a hydrophobic covering over a polymeric matrix [93]. 
The main objective in future research regarding lowered microparticle concentrations is 
to focus on improving of the properties of the silica hydrogel matrix. Rapid increase in 
viscosity in the matrix is essential in stabilizing the microparticles. As a conclusion, 
either additives in the hydrogel matrix or adding microparticles to a gel could be inves-
tigated in the future in order to obtain composites with low microparticle concentra-
tions. 
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SUPPLEMENTS 
Figures of injection force measurements of stored formulations R150 Cmp=0.4;0.3 g/ml 
are presented below. The results are presented for five time points (1 d, 14 d, 30 d, 60 d, 
90 d). The amount of composite injected out (μl) is plotted as a function of injection 
force (N). The maximum finger press force of an adult is approximately 100 N. [57] 
 
Figure 23. Injection force measurements of R150 Cmp=0.3 g/ml and 0.4 g/ml stored for 
24 hours in room temperature. Two syringes of both formulations were measured and 
the filling of the syringes was 1000 μl. All syringes were blocked. 
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Figure 24. Injection force measurements of R150 Cmp=0.3 g/ml and 0.4 g/ml stored for 
two weeks in +37°C. Two syringes of both formulations were measured and the filling 
of the syringes was 1000 μl. One injection was successful. 
 
Figure 25. Injection force measurements of R150 Cmp=0.3 g/ml and 0.4 g/ml stored for 
one month in 37°C. Two syringes of both formulations were measured and the filling of 
the syringes was 1000 μl. All syringes were blocked. 
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Figure 26. Injection force measurements of R150 Cmp=0.3 g/ml and 0.4 g/ml stored for 
two months in +37°C. Two syringes of both formulations were measured and the filling 
of the syringes was 1000 μl. All injections were successful. 
 
Figure 27. Injection force measurements of R150 Cmp=0.3 g/ml and 0.4 g/ml stored for 
three months in +37°C. Two syringes of both formulations were measured and the fill-
ing of the syringes was 1000 μl. Two injections were successful. 
